Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small conductance calcium-activated potassium channel 2 (SK2) is a subtype of SK channels, which are potassium-selective ion channels activated by increases in intracellular calcium concentration. These channels play critical roles in regulating membrane potential and excitability in various cell types, especially neurons and cardiomyocytes. SK2 channels are tetrameric complexes composed of four α-subunits, each containing six transmembrane domains (S1–S6), with a pore-forming loop between S5 and S6 that determines potassium selectivity. Calmodulin (CaM) is constitutively bound, conferring calcium sensitivity. Activation leads to K⁺ efflux, causing membrane hyperpolarization. In neurons, it mediates slow afterhyperpolarization (sAHP) following action potentials, limiting firing frequency. Apamin is a selective blocker.
Channel blocker
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Conductance Calcium-Activated Potassium Channel 2 (SK2).